Applications
Find Fully Human Hits in Weeks with Single B-Cell Screening
HuTg mice, like our DiversimAb platform, generate potent, highly-specific therapeutic and reagent antibody candidates. Both platforms are fully compatible with our Beacon-based single B-cell screening, enabling high-resolution, high-throughput hit identification and sequencing in a few weeks. Twist’s HuTg mouse workflow is particularly well suited for single B-cell screening, as they generate highly productive and active B cell populations, which is not typically seen with other humanized mouse platforms.
Hybridoma-Compatible Workflow
Twist also provides an end-to-end, adaptable hybridoma workflow for HuTg and DiversimAb mice that includes hybridoma generation, high-throughput screening, and sequencing to uncover promising hits.